With global perspective while rooted in China, InnoCare is a biopharmaceutical company focused on discovery and development of innovative drug for treatment of cancer and autoimmune diseases. Founded by world-renowned structural biologists and world top scientists, InnoCare has a core scientific team with solid education background and rich drug discovery experience in the US and a strong Scientific Advisory Board (SAB) which consists of academic leaders from top universities, famous scientists from pharmaceutical industry and clinical experts from national top hospitals. InnoCare is aggressively forging an important pathway forward in defeating disease and pushing the innovation boundaries into unchartered territories.

InnoCare是一家植根中国且具全球视野的新药创制公司。公司由世界著名的结构生物学家和在国际顶尖制药公司积累数十年经验的新药研究专家共同发起设立，核心研究团队成员都有长期在美国学习和在跨国制药公司担任研发高管的经历。他们与由来自清华、北大的生命科学领域学术带头人、跨国制药公司新药研究专家以及国内顶尖医院的医疗专家组成的科学顾问委员会一起，构成公司核心竞争力的重要组成部分。